| pubmed-article:17245540 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0039286 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0290883 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0232970 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C1363878 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C1710684 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0010181 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0677850 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0018696 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0878174 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0205197 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C2348557 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C1556116 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C1556117 | lld:lifeskim |
| pubmed-article:17245540 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:17245540 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17245540 | pubmed:dateCreated | 2007-10-31 | lld:pubmed |
| pubmed-article:17245540 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17245540 | pubmed:abstractText | This study evaluated the cost-effectiveness of anastrozole versus generic tamoxifen for primary adjuvant treatment of postmenopausal women with hormone receptor-positive (HR+) early breast cancer (EBC), from a US healthcare perspective. | lld:pubmed |
| pubmed-article:17245540 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17245540 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17245540 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17245540 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17245540 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17245540 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17245540 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17245540 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17245540 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17245540 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:17245540 | pubmed:issn | 0167-6806 | lld:pubmed |
| pubmed-article:17245540 | pubmed:author | pubmed-author:ATAC... | lld:pubmed |
| pubmed-article:17245540 | pubmed:author | pubmed-author:CellaDavidD | lld:pubmed |
| pubmed-article:17245540 | pubmed:author | pubmed-author:ManselRobertR | lld:pubmed |
| pubmed-article:17245540 | pubmed:author | pubmed-author:GandhiSanjay... | lld:pubmed |
| pubmed-article:17245540 | pubmed:author | pubmed-author:DobrezDeborah... | lld:pubmed |
| pubmed-article:17245540 | pubmed:author | pubmed-author:LockerGershon... | lld:pubmed |
| pubmed-article:17245540 | pubmed:author | pubmed-author:SorensenSonja... | lld:pubmed |
| pubmed-article:17245540 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17245540 | pubmed:volume | 106 | lld:pubmed |
| pubmed-article:17245540 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17245540 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17245540 | pubmed:pagination | 229-38 | lld:pubmed |
| pubmed-article:17245540 | pubmed:dateRevised | 2008-4-14 | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:meshHeading | pubmed-meshheading:17245540... | lld:pubmed |
| pubmed-article:17245540 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17245540 | pubmed:articleTitle | Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen Alone or in Combination) trial. | lld:pubmed |
| pubmed-article:17245540 | pubmed:affiliation | Evanston Northwestern Healthcare, 2650 Ridge Room 5134, Evanston, IL 60201, USA. gylocker@northwestern.edu | lld:pubmed |
| pubmed-article:17245540 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17245540 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17245540 | lld:pubmed |
